Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Transmission of NS5A resistance associated substitutions among men-who-have-sex-with-men recently infected with hepatitis C virus genotype 1a.

Popping S, Verwijs R, Cuypers L, Claassen M, van den Berk G, De Weggheleire A, Arends J, Boerekamps A, Molenkamp R, Koopmans M, Verbon A, Boucher C, Rijnders B, van de Vijver D.

Clin Infect Dis. 2020 Feb 14. pii: ciaa145. doi: 10.1093/cid/ciaa145. [Epub ahead of print]

PMID:
32055843
2.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C.

Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.

3.

Performance evaluation of the Panther Fusion® respiratory tract panel.

Voermans JJC, Mulders DGJC, Pas SD, Koopmans MPG, van der Eijk AA, Molenkamp R.

J Clin Virol. 2020 Feb;123:104232. doi: 10.1016/j.jcv.2019.104232. Epub 2019 Dec 10.

4.

Bile-salt stimulated lipase polymorphisms do not associate with HCV susceptibility.

Steba GS, Koekkoek SM, Prins M, Brinkman K, Kwa D, van der Meer JTM, van der Valk M, Molenkamp R, Pollakis G, Schinkel J, Paxton WA; MOSAIC (MSM observational Study of Acute infection with Hepatitis C) study group.

Virus Res. 2019 Dec;274:197715. doi: 10.1016/j.virusres.2019.197715. Epub 2019 Oct 14.

PMID:
31622635
5.

Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands.

Phan MVT, Arron G, GeurtsvanKessel CH, Huisman RC, Molenkamp R, Koopmans MPG, Cotten M.

Microbiol Resour Announc. 2019 Apr 11;8(15). pii: e00125-19. doi: 10.1128/MRA.00125-19.

6.

HIV-1 exposure and immune activation enhance sexual transmission of Hepatitis C virus by primary Langerhans cells.

Nijmeijer BM, Sarrami-Forooshani R, Steba GS, Schreurs RR, Koekkoek SM, Molenkamp R, Schinkel J, Reiss P, Siegenbeek van Heukelom ML, van der Valk M, Ribeiro CM, Geijtenbeek TB.

J Int AIDS Soc. 2019 Mar;22(3):e25268. doi: 10.1002/jia2.25268.

7.

Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.

Merat SJ, Bru C, van de Berg D, Molenkamp R, Tarr AW, Koekkoek S, Kootstra NA, Prins M, Ball JK, Bakker AQ, de Jong MD, Spits H, Beaumont T, Schinkel J.

J Hepatol. 2019 Jul;71(1):14-24. doi: 10.1016/j.jhep.2019.02.013. Epub 2019 Feb 21.

PMID:
30797052
8.

Genomic sequence of yellow fever virus from a Dutch traveller returning from the Gambia-Senegal region, the Netherlands, November 2018.

Phan MV, Murad SD, van der Eijk AA, Metselaar HJ, Hartog H, Harinck F, GeurtsvanKessel CH, Molenkamp R, Cotten M, Koopmans MP.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1800684.

9.

High-Resolution Evolutionary Analysis of Within-Host Hepatitis C Virus Infection.

Raghwani J, Wu CH, Ho CKY, De Jong M, Molenkamp R, Schinkel J, Pybus OG, Lythgoe KA.

J Infect Dis. 2019 May 5;219(11):1722-1729. doi: 10.1093/infdis/jiy747.

10.

SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibility.

Steba GS, Koekkoek SM, Tanck MWT, Vanhommerig JW, van der Meer JTM, Kwa D, Brinkman K, Prins M, Berkhout B, Pollakis G, Molenkamp R, Schinkel J, Paxton WA; MOSAIC (MSM observational Study of Acute infection with Hepatitis C) Study Group and the ACS (Amsterdam Cohort Studies).

Liver Int. 2019 Mar;39(3):463-469. doi: 10.1111/liv.13978. Epub 2018 Oct 17.

11.

Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV/HCV-coinfected MSM with risk of onward transmission.

Newsum AM, Molenkamp R, van der Meer JT, Rebers SP, Prins M, van der Valk M, Schinkel J.

J Hepatol. 2018 Oct;69(4):968-970. doi: 10.1016/j.jhep.2018.06.021. Epub 2018 Jul 4. No abstract available.

PMID:
30227918
12.

DC-SIGN Polymorphisms Associate with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.

Steba GS, Koekkoek SM, Vanhommerig JW, Brinkman K, Kwa D, Van Der Meer JTM, Prins M, Berkhout B, Tanck M, Paxton WA, Molenkamp R, Schinkel J; MSM Observational Study of Acute Infection with Hepatitis C (MOSAIC) Study Group and Amsterdam Cohort Studies (ACS).

J Infect Dis. 2018 Jan 17;217(3):353-357. doi: 10.1093/infdis/jix587.

13.

Respiratory Viruses in Invasively Ventilated Critically Ill Patients-A Prospective Multicenter Observational Study.

van Someren Gréve F, Juffermans NP, Bos LDJ, Binnekade JM, Braber A, Cremer OL, de Jonge E, Molenkamp R, Ong DSY, Rebers SPH, Spoelstra-de Man AME, van der Sluijs KF, Spronk PE, Verheul KD, de Waard MC, de Wilde RBP, Winters T, de Jong MD, Schultz MJ.

Crit Care Med. 2018 Jan;46(1):29-36. doi: 10.1097/CCM.0000000000002752.

PMID:
28991822
14.

Multiplex flow cytometry-based assay to study the breadth of antibody responses against E1E2 glycoproteins of hepatitis C virus.

Merat SJ, van de Berg D, Bru C, Yasuda E, Breij E, Kootstra N, Prins M, Molenkamp R, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T.

J Immunol Methods. 2018 Mar;454:15-26. doi: 10.1016/j.jim.2017.07.015. Epub 2017 Aug 30.

PMID:
28855105
15.

Travel-related acquisition of diarrhoeagenic bacteria, enteral viruses and parasites in a prospective cohort of 98 Dutch travellers.

van Hattem JM, Arcilla MS, Grobusch MP, Bart A, Bootsma MC, van Genderen PJ, van Gool T, Goorhuis A, van Hellemond JJ, Molenkamp R, Molhoek N, Oude Lashof AM, Stobberingh EE, de Wever B, Verbrugh HA, Melles DC, Penders J, Schultsz C, de Jong MD.

Travel Med Infect Dis. 2017 Sep;19:33-36. doi: 10.1016/j.tmaid.2017.08.003. Epub 2017 Aug 24.

16.

Limited overlap between phylogenetic HIV and hepatitis C virus clusters illustrates the dynamic sexual network structure of Dutch HIV-infected MSM.

Vanhommerig JW, Bezemer D, Molenkamp R, Van Sighem AI, Smit C, Arends JE, Lauw FN, Brinkman K, Rijnders BJ, Newsum AM, Bruisten SM, Prins M, Van Der Meer JT, Van De Laar TJ, Schinkel J; MOSAIC study and the ATHENA national observational cohort.

AIDS. 2017 Sep 24;31(15):2147-2158. doi: 10.1097/QAD.0000000000001592.

PMID:
28692530
17.

Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.

de Niet A, Jansen L, Stelma F, Willemse SB, Kuiken SD, Weijer S, van Nieuwkerk CMJ, Zaaijer HL, Molenkamp R, Takkenberg RB, Koot M, Verheij J, Beuers U, Reesink HW.

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):576-584. doi: 10.1016/S2468-1253(17)30083-3. Epub 2017 May 15.

PMID:
28522204
18.

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.

van der Ree MH, de Vree JM, Stelma F, Willemse S, van der Valk M, Rietdijk S, Molenkamp R, Schinkel J, van Nuenen AC, Beuers U, Hadi S, Harbers M, van der Veer E, Liu K, Grundy J, Patick AK, Pavlicek A, Blem J, Huang M, Grint P, Neben S, Gibson NW, Kootstra NA, Reesink HW.

Lancet. 2017 Feb 18;389(10070):709-717. doi: 10.1016/S0140-6736(16)31715-9. Epub 2017 Jan 11.

PMID:
28087069
19.

Characterization of Hepatitis C Virus (HCV) Envelope Diversification from Acute to Chronic Infection within a Sexually Transmitted HCV Cluster by Using Single-Molecule, Real-Time Sequencing.

Ho CKY, Raghwani J, Koekkoek S, Liang RH, Van der Meer JTM, Van Der Valk M, De Jong M, Pybus OG, Schinkel J, Molenkamp R.

J Virol. 2017 Feb 28;91(6). pii: e02262-16. doi: 10.1128/JVI.02262-16. Print 2017 Mar 15.

20.

Assay optimization for molecular detection of Zika virus.

Corman VM, Rasche A, Baronti C, Aldabbagh S, Cadar D, Reusken CB, Pas SD, Goorhuis A, Schinkel J, Molenkamp R, Kümmerer BM, Bleicker T, Brünink S, Eschbach-Bludau M, Eis-Hübinger AM, Koopmans MP, Schmidt-Chanasit J, Grobusch MP, de Lamballerie X, Drosten C, Drexler JF.

Bull World Health Organ. 2016 Dec 1;94(12):880-892.

21.

The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.

Newsum AM, Ho CK, Lieveld FI, van de Laar TJ, Koekkoek SM, Rebers SP, van der Meer JT, Wensing AM, Boland GJ, Arends JE, van Erpecum KJ, Prins M, Molenkamp R, Schinkel J.

AIDS. 2017 Jan 2;31(1):105-112.

PMID:
27898592
22.

Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.

Merat SJ, Molenkamp R, Wagner K, Koekkoek SM, van de Berg D, Yasuda E, Böhne M, Claassen YB, Grady BP, Prins M, Bakker AQ, de Jong MD, Spits H, Schinkel J, Beaumont T.

PLoS One. 2016 Oct 24;11(10):e0165047. doi: 10.1371/journal.pone.0165047. eCollection 2016.

23.

Prevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname.

Mac Donald-Ottevanger MS, Vreden S, van der Helm JJ, van de Laar T, Molenkamp R, Dams E, Roosblad J, Codrington J, Hindori-Mohangoo AD, Prins M.

Virology. 2016 Dec;499:114-120. doi: 10.1016/j.virol.2016.07.001. Epub 2016 Sep 19.

24.

 Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection.

Lieveld FI, Swaans N, Newsum AM, Ho CK, Schinkel J, Molenkamp R, van der Meer JT, Arends JE, Hoepelman AI, Wensing AM, Siersema PD, van Erpecum KJ, Boland GJ.

Ann Hepatol. 2016 Sep-Oct;15(5):696-704. doi: 10.5604/16652681.1212426.

25.

Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.

Tholen AT, Schinkel J, Molenkamp R, Ang CW.

PLoS One. 2016 Feb 3;11(2):e0146906. doi: 10.1371/journal.pone.0146906. eCollection 2016.

26.

Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study.

Vanhommerig JW, Lambers FA, Schinkel J, Geskus RB, Arends JE, van de Laar TJ, Lauw FN, Brinkman K, Gras L, Rijnders BJ, van der Meer JT, Prins M; MOSAIC (MSM Observational Study of Acute Infection With Hepatitis C) Study Group, van der Meer JT, Molenkamp R, Mutschelknauss M, Nobel HE, Reesink HW, Schinkel J, van der Valk M, van den Berk GE, Brinkman K, Kwa D, van der Meche N, Toonen A, Vos D, van Broekhuizen M, Lauw FN, Mulder JW, Arends JE, van Kessel A, de Kroon I, Boonstra A, van der Ende ME, Hullegie S, Rijnders BJ, van de Laar TJ, Gras L, Smit C, Lambers FA, Prins M, Vanhommerig JW, van der Veldt W.

Open Forum Infect Dis. 2015 Aug 6;2(3):ofv115. doi: 10.1093/ofid/ofv115. eCollection 2015 Sep.

27.

Changes in microbiota during experimental human Rhinovirus infection.

Hofstra JJ, Matamoros S, van de Pol MA, de Wever B, Tanck MW, Wendt-Knol H, Deijs M, van der Hoek L, Wolthers KC, Molenkamp R, Visser CE, Sterk PJ, Lutter R, de Jong MD.

BMC Infect Dis. 2015 Aug 14;15:336. doi: 10.1186/s12879-015-1081-y.

28.

Genetic characterization of multiple hepatitis C virus infections following acute infection in HIV-infected men who have sex with men.

Thomas XV, Grady BP, Van Der Meer JT, Ho CK, Vanhommerig JW, Rebers SP, De Jong MD, Van Der Valk M, Prins M, Molenkamp R, Schinkel J; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group.

AIDS. 2015 Nov;29(17):2287-95. doi: 10.1097/QAD.0000000000000838.

PMID:
26258527
29.

A comparison of 454 sequencing and clonal sequencing for the characterization of hepatitis C virus NS3 variants.

Ho CKY, Welkers MRA, Thomas XV, Sullivan JC, Kieffer TL, Reesink HW, Rebers SPH, de Jong MD, Schinkel J, Molenkamp R.

J Virol Methods. 2015 Jul;219:28-37. doi: 10.1016/j.jviromet.2015.03.018. Epub 2015 Mar 26.

PMID:
25818622
30.

Culturing of respiratory viruses in well-differentiated pseudostratified human airway epithelium as a tool to detect unknown viruses.

Farsani SM, Deijs M, Dijkman R, Molenkamp R, Jeeninga RE, Ieven M, Goossens H, van der Hoek L.

Influenza Other Respir Viruses. 2015 Jan;9(1):51-7. doi: 10.1111/irv.12297. Epub 2014 Dec 8.

31.

IP-10 in chronic hepatitis C patients treated with high-dose interferon.

Willemse SB, Reesink HW, Ladee K, Karlas J, Gelderblom HC, Molenkamp R, Schinkel J.

Neth J Med. 2014 Oct;72(8):407-15.

32.

Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men.

Vanhommerig JW, Thomas XV, van der Meer JT, Geskus RB, Bruisten SM, Molenkamp R, Prins M, Schinkel J; MOSAIC (MSM Observational Study for Acute Infection with hepatitis C) Study Group.

Clin Infect Dis. 2014 Dec 15;59(12):1678-85. doi: 10.1093/cid/ciu695. Epub 2014 Sep 3.

PMID:
25186590
33.

BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion.

Grady BP, Prins M, Rebers S, Molenkamp R, Geskus RB, Schinkel J.

J Viral Hepat. 2015 Mar;22(3):263-71. doi: 10.1111/jvh.12303. Epub 2014 Sep 1.

PMID:
25174990
34.

Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study.

Majoor CJ, van de Pol MA, Kamphuisen PW, Meijers JC, Molenkamp R, Wolthers KC, van der Poll T, Nieuwland R, Johnston SL, Sterk PJ, Bel EH, Lutter R, van der Sluijs KF.

Respir Res. 2014 Feb 7;15:14. doi: 10.1186/1465-9921-15-14.

35.

Unexplained diarrhoea in HIV-1 infected individuals.

Oude Munnink BB, Canuti M, Deijs M, de Vries M, Jebbink MF, Rebers S, Molenkamp R, van Hemert FJ, Chung K, Cotten M, Snijders F, Sol CJ, van der Hoek L.

BMC Infect Dis. 2014 Jan 13;14:22. doi: 10.1186/1471-2334-14-22.

36.

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor.

de Bruijne J, Thomas XV, Rebers SP, Weegink CJ, Treitel MA, Hughes E, Bergmann JF, de Knegt RJ, Janssen HL, Reesink HW, Molenkamp R, Schinkel J.

J Viral Hepat. 2013 Nov;20(11):779-89. doi: 10.1111/jvh.12104. Epub 2013 Jun 27.

PMID:
24168257
37.

Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design.

van der Sluijs KF, van de Pol MA, Kulik W, Dijkhuis A, Smids BS, van Eijk HW, Karlas JA, Molenkamp R, Wolthers KC, Johnston SL, van der Zee JS, Sterk PJ, Lutter R; RESOLVE research team.

Thorax. 2013 Dec;68(12):1122-30. doi: 10.1136/thoraxjnl-2013-203728. Epub 2013 Jul 23.

PMID:
23882022
38.

Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies.

Jansen RR, Biemond BJ, Schinkel J, Koekkoek SM, Molenkamp R, de Jong MD, Visser CE.

Virol J. 2013 Jun 27;10:212. doi: 10.1186/1743-422X-10-212.

39.

Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.

Takkenberg RB, Jansen L, de Niet A, Zaaijer HL, Weegink CJ, Terpstra V, Dijkgraaf MG, Molenkamp R, Jansen PL, Koot M, Rijckborst V, Janssen HL, Beld MG, Reesink HW.

Antivir Ther. 2013;18(7):895-904.

PMID:
23639931
40.

Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism.

Dijkman R, Jebbink MF, Koekkoek SM, Deijs M, Jónsdóttir HR, Molenkamp R, Ieven M, Goossens H, Thiel V, van der Hoek L.

J Virol. 2013 Jun;87(11):6081-90. doi: 10.1128/JVI.03368-12. Epub 2013 Feb 20.

41.

Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.

Pas S, Molenkamp R, Schinkel J, Rebers S, Copra C, Seven-Deniz S, Thamke D, de Knegt RJ, Haagmans BL, Schutten M.

J Clin Microbiol. 2013 Jan;51(1):238-42. doi: 10.1128/JCM.01729-12. Epub 2012 Nov 14.

42.

Performance of VIDISCA-454 in feces-suspensions and serum.

de Vries M, Oude Munnink BB, Deijs M, Canuti M, Koekkoek SM, Molenkamp R, Bakker M, Jurriaans S, van Schaik BD, Luyf AC, Olabarriaga SD, van Kampen AH, van der Hoek L.

Viruses. 2012 Aug;4(8):1328-34. doi: 10.3390/v4081328. Epub 2012 Aug 22.

43.

The first complete genome sequences of clinical isolates of human coronavirus 229E.

Farsani SM, Dijkman R, Jebbink MF, Goossens H, Ieven M, Deijs M, Molenkamp R, van der Hoek L.

Virus Genes. 2012 Dec;45(3):433-9. doi: 10.1007/s11262-012-0807-9. Epub 2012 Aug 25.

PMID:
22926811
44.

Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevir.

Thomas XV, de Bruijne J, Sullivan JC, Kieffer TL, Ho CK, Rebers SP, de Vries M, Reesink HW, Weegink CJ, Molenkamp R, Schinkel J.

PLoS One. 2012;7(7):e41191. doi: 10.1371/journal.pone.0041191. Epub 2012 Jul 27.

45.

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design.

Hotho DM, de Bruijne J, O'Farrell AM, Boyea T, Li J, Bracken M, Li X, Campbell D, Guler HP, Weegink CJ, Schinkel J, Molenkamp R, van de Wetering de Rooij J, van Vliet A, Janssen HL, de Knegt RJ, Reesink HW.

Antivir Ther. 2012;17(2):365-75. doi: 10.3851/IMP1989. Epub 2011 Nov 30.

PMID:
22293533
46.

Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection.

de Vries JJ, van der Eijk AA, Wolthers KC, Rusman LG, Pas SD, Molenkamp R, Claas EC, Kroes AC, Vossen AC.

J Clin Virol. 2012 Feb;53(2):167-70. doi: 10.1016/j.jcv.2011.11.006. Epub 2011 Dec 15.

PMID:
22177273
47.

Dynamic changes in HCV RNA levels and viral quasispecies in a patient with chronic hepatitis C after telaprevir-based treatment.

de Bruijne J, Sullivan JC, Kieffer TL, Botfield M, Shames B, Schinkel J, Molenkamp R, Weegink C, Reesink H.

J Clin Virol. 2012 Feb;53(2):174-7. doi: 10.1016/j.jcv.2011.11.004. Epub 2011 Dec 3.

PMID:
22138301
48.

Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.

Raghwani J, Thomas XV, Koekkoek SM, Schinkel J, Molenkamp R, van de Laar TJ, Takebe Y, Tanaka Y, Mizokami M, Rambaut A, Pybus OG.

J Virol. 2012 Feb;86(4):2212-20. doi: 10.1128/JVI.06184-11. Epub 2011 Nov 23.

49.

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort.

van den Berg CH, Grady BP, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, Coutinho RA, van Baarle D, Prins M.

PLoS One. 2011;6(11):e27555. doi: 10.1371/journal.pone.0027555. Epub 2011 Nov 15.

50.

Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.

Lambers FA, Prins M, Thomas X, Molenkamp R, Kwa D, Brinkman K, van der Meer JT, Schinkel J; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group.

AIDS. 2011 Nov 13;25(17):F21-7. doi: 10.1097/QAD.0b013e32834bac44.

PMID:
21857492

Supplemental Content

Loading ...
Support Center